Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ï¿¥190,785.33, with a 24-hour trading volume of ï¿¥412.71B. The asset's market cap is ï¿¥170.13T, after moving 0.85% in the last day.
Tokenized Eli Lilly And Co is trading at ï¿¥192,256.24, with a tokenized market cap of ï¿¥7.47B and a 24-hour trading volume of ï¿¥249.42M. The tokenized asset has moved -1.17% in the past 24 hours.